Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL

Newly Augmented Microdispenser System Replaces Five Liquid Handling Instruments

By BiotechDaily International staff writers
Posted on 13 Apr 2014
Image: The MultiFlo FX Multi-Mode Dispenser with the BioStack 4, for lidded or unlidded plates (Photo courtesy of Biotek Instruments, Inc.).
Image: The MultiFlo FX Multi-Mode Dispenser with the BioStack 4, for lidded or unlidded plates (Photo courtesy of Biotek Instruments, Inc.).
Upgrades to a highly regarded microdispenser system allows the instrument fo replace up to five separate liquid handlers, saving operator time and instrumentation costs

The new BioTek (Winooski, VT, USA) MultiFlo FX Microplate Dispenser is now available with optional RAD (Random Access Dispense) technology to further extend its application range and flexibility. RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24-well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
The Multiflo FX accommodates microplate types ranging from 6- to 1536-wells, and dispenses volumes of from one to three microliters accurately and precisely. BioTek's proprietary angled dispensing ensures compatibility with all dispense protocols including media exchanges with loosely adherent cell monolayers. For assays requiring minimum reagent usage, the MultiFlo's prime volume is less than one milliliter. A built-in priming trough is designed to allow both recovery of reagents or to send primed reagent directly to waste.

MultiFlo FX was especially designed for sensitive cell-based assays, ELISAs, and bead-based assays, with angled dispense tips and flexible flow rates to maintain cell integrity.

Due to its small footprint and base height of less than 20.3 cm, the MultiFlo FX readily fits on any laboratory bench or robotic system. It is easily integrated with the BioTek BioStack Microplate Stacker, allowing up to 75 plates to be dispensed automatically. Simplified programming via intuitive on-board software and a color touch screen display enable control of dispense patterns, and two integrated USB ports provide convenient file transfer and storage options.

“Microplate-based bulk dispensing can be complex, especially in an automated system,” said Jason Greene, BioTek product manager. “We specifically designed MultiFlo FX to streamline this process, providing more value through multitasking, and time savings.”

Related Links:
BioTek



Channels

Genomics/Proteomics

view channel
Image: The photomicrograph shows the head of a mouse embryo in which the pericytes are visible as blue dots along the blood vessel (Photo courtesy of the University of Gothenburg).

Genetically Engineered Mouse Model Reveals Key to Formation of the Blood-Brain Barrier

Use of a mouse model that had been genetically engineered to lack the gene that encodes the forkhead transcription factor Foxf2 has helped to explain how pericytes, cells that line the capillaries, form... Read more

Drug Discovery

view channel
Image: Neurons cultivated with the help of ordinary skin cells create a three-dimensional network on a chip (Photo courtesy of Dr. Edinson Lucumi Moreno, University of Luxembourg).

Bioreactor Culture of Dopamine-Producing Neurons May Lead to Personalized Treatment of Parkinson's Disease

By developing a procedure for transforming skin cells into functional dopamine-producing neurons, researchers have taken an important first step towards the development of personalized treatment of Parkinson's... Read more

Business

view channel

Biopharm Startup to Commercialize Antibody Therapy for Drug Resistant Cancers

A biopharm startup company has licensed the rights to commercialize an antibody-based approach for treatment of drug resistant cancers. The new company, CadheRx Therapeutics (La Jolla, CA, USA), entered into a licensing agreement with Stony Brook University (NY, USA) to develop and market an anticancer technology derived... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.